Frank Meng
Biographic Data
| ID | 7707980 |
|---|---|
| NAME | Frank Meng |
| GIVEN NAMES | Frank |
| FAMILY NAME | Meng |
| SIGNATURE | MENG F |
| AFFILIATIONS | VA Boston Healthcare System |
| ORCID | 0000-0002-3065-1619 |
| VERIFIED | Yes |
| TOTAL WORKS | 3 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 3 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2024 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 0 |
Racial and ethnic differences in buprenorphine initiation and retention prior to and after Covid-19
Objective Evaluate racial and ethnic differences in the duration of buprenorphine treatment among veterans diagnosed with opioid use disorder (OUD) between 2016 and 2021.Method A longitudinal retrospective cohort analysis was conducted using nationwide Veterans Health Administration electronic health records. The study included veterans diagnosed with OUD between January 14, 2016, to April 1, 2021. The main outcome was the duration of continuous …
Sex Differences in Suicide, Lethal Means, and Years of Potential Life Lost Among Veterans With Substance Use Disorder
Impact of the Covid-19 pandemic on health care utilization for commercial and Medicaid beneficiaries with opioid use disorder
Introduction We sought to examine how COVID-19 affected opioid use disorder (OUD)-specific health care utilization for insured individuals with preexisting OUD during the first year of the pandemic
No prominent works on this page.
Impact of the Covid-19 pandemic on health care utilization for commercial and Medicaid beneficiaries with opioid use disorder
Introduction We sought to examine how COVID-19 affected opioid use disorder (OUD)-specific health care utilization for insured individuals with preexisting OUD during the first year of the pandemic
Sex Differences in Suicide, Lethal Means, and Years of Potential Life Lost Among Veterans With Substance Use Disorder
Racial and ethnic differences in buprenorphine initiation and retention prior to and after Covid-19
Objective Evaluate racial and ethnic differences in the duration of buprenorphine treatment among veterans diagnosed with opioid use disorder (OUD) between 2016 and 2021.Method A longitudinal retrospective cohort analysis was conducted using nationwide Veterans Health Administration electronic health records. The study included veterans diagnosed with OUD between January 14, 2016, to April 1, 2021. The main outcome was the duration of continuous …
Medicine (2 works) · Opioid use disorder (2 works) · Opioid Use Disorder Treatment (2 works) · Suicide and Self-Harm Studies (2 works) · 2019-20 coronavirus outbreak (1 works) · Buprenorphine (1 works) · Business (1 works) · Cohort (1 works) · Cohort study (1 works) · Coronavirus disease 2019 (COVID-19 (1 works)